Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Sensus Healthcare, Inc. (SRTS)

$3.03 +3.06% NASDAQ: SRTS · 15-min delayed
  • BOCA RATON, Florida
  • Public · NASDAQ: SRTS
  • 60 employees
$44.4MMarket cap
$27.5MRevenue · FY2025
-$7.7MNet income
60Employees
SRTSNASDAQ
2016IPO

About Sensus Healthcare, Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$27.5M
Net income
-$7.7M
Total assets
$53.0M
Market cap
$44.4M
Gross margin
43.2%
Operating margin
-37.5%
Net margin
-28.1%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$27.5M
Cost of revenue
$15.6M
Gross profit
$11.9M
Operating expenses
$22.2M
Operating income
-$10.3M
Income tax
-$1.9M
Net income
-$7.7M
EPS (basic)
$-0.47
EPS (diluted)
$-0.47

Balance sheet

Total assets
$53.0M
Current assets
$45.9M
Total liabilities
$4.9M
Current liabilities
$4.7M
Shareholders’ equity
$48.1M

Cash flow

Operating cash flow
$528.0K
Investing cash flow
-$196.0K
Financing cash flow
-$305.0K
Net cash flow
$27.0K

Statements via Polygon.io (SEC filings)

NASDAQ: SRTS
$3.03 +3.06%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.69 $5.65

52-week range

Market cap
$44.4M
EPS (diluted)
$-0.47
Shares outstanding
14.7M
Open
Day range
Prev close
Volume
IPO date
Jul 25, 2016

Sensus Healthcare, Inc. (SRTS) Stock Price

  • Reported a net loss of $7.7M in FY2025.
  • Revenue grew 2% from FY2021 to FY2025.
  • Gross margin of 43.2%, net margin -28.1%.
  • Trading 46% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Sensus Healthcare, Inc..

Write a review
Newsroom

News about Sensus Healthcare, Inc.

News & sentiment via Polygon.io

FAQ

Sensus Healthcare, Inc.: frequently asked questions

Is Sensus Healthcare, Inc. an American company?

Sensus Healthcare, Inc. is a US-based company headquartered in Boca Raton, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Sensus Healthcare, Inc. headquartered?

Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida, United States.

Is Sensus Healthcare, Inc. publicly traded?

Yes — Sensus Healthcare, Inc. is a publicly traded company. Its stock trades under the ticker symbol SRTS on the NASDAQ.

What does Sensus Healthcare, Inc. do?

Sensus Healthcare, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →